Guanoxabenz: Difference between revisions
No edit summary |
No edit summary |
||
Line 28: | Line 28: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== |
Revision as of 00:10, 25 July 2014
WikiDoc Resources for Guanoxabenz |
Articles |
---|
Most recent articles on Guanoxabenz Most cited articles on Guanoxabenz |
Media |
Powerpoint slides on Guanoxabenz |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Guanoxabenz at Clinical Trials.gov Clinical Trials on Guanoxabenz at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Guanoxabenz
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Guanoxabenz Discussion groups on Guanoxabenz Patient Handouts on Guanoxabenz Directions to Hospitals Treating Guanoxabenz Risk calculators and risk factors for Guanoxabenz
|
Healthcare Provider Resources |
Causes & Risk Factors for Guanoxabenz |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Guanoxabenz is a metabolite of guanabenz.